Advancements in Lung Cancer Precision Oncology Research and Treatments

Access to an extensive molecular profiling is becoming imperative for all patients with NSCLC. As consequence, the diagnosis and management of NSCLC is getting more complicated with the development of newer and more specific therapies for the different molecular subtypes. Considering this evolving landscape, we have conceived this Special Issue aimed at exploring recent advances in precision medicine and immunotherapy, as well as the underlying mechanisms of treatment resistance and potential strategies to overcome them in patients with lung cancer.